Skip to main content

Table 1 Baseline clinical, echocardiographic and CMR data

From: Sex-based differences in left ventricular remodeling in patients with chronic aortic regurgitation: a multi-modality study

 

Male (n = 185)

Female (n = 58)

Total (n = 243)

p-value

Clinical data

   

Age (years)

46.8 ± 16.5

53.2 ± 16.2

48.3 ± 16.6

0.017

Heart rate (beats per minute)

67 ± 12

75 ± 12

69 ± 13

 < 0.001

Systolic blood pressure (mmHg)

129 ± 18

128 ± 21

129 ± 19

0.439

Diastolic blood pressure (mmHg)

68 ± 12

69 ± 12

68 ± 12

0.576

Body mass index

27.7 ± 5.1

28.2 ± 6.6

27.8 ± 5.5

0.635

Height (cm)

178.5 ± 7.5

163.5 ± 6.4

175.2 ± 9.5

 < 0.001

Type of aortic valve

    

 Unicuspid

 Bicuspid

 Tricuspid

 Quadricuspid

2 (1.1%)

128 (70.7%)

50 (27.6%)

0

0

20 (34.5%)

37 (63.8%)

1 (1.7%)

2 (0.8%)

148 (61.9%)

87 (36.4%)

1 (0.4%)

 < 0.001

Dilated ascending aorta (> 4 cm)

74 (43.3%)

27 (49.1%)

101 (44.7%)

0.451

Coronary artery disease

17 (9.2%)

8 (13.8%)

25 (10.3%)

0.314

Atrial fibrillation

16 (8.7%)

1 (1.7%)

17 (7.0%)

0.071

Chronic kidney disease

6 (3.2%)

4 (6.9%)

10 (4.1%)

0.222

Diabetes mellitus

9 (4.9%)

1 (1.7%)

10 (4.1%)

0.293

Hypertension

94 (50.8%)

34 (58.6%)

128 (52.7%)

0.299

NYHA class:

    

 1

 2

 3

139 (75.1%)

38 (20.5%)

7 (3.8%)

29 (50.0%)

23 (39.7%)

6 (10.3%)

168 (69.1%)

61 (25.1%)

13 (5.4%)

0.003

Echocardiographic data indexed to BSA

   

 LVEDVI (ml/m2)

87.0 ± 31.5

60.1 ± 24.0

81.0 ± 32.0

 < 0.001

 LVESVI (ml/m2)

35.9 ± 18.4

25.0 ± 14.2

33.5 ± 18.1

 < 0.001

 LVEDDI (cm/m2)

2.8 ± 0.57

2.6 ± 0.44

2.7 ± 0.50

0.041

 LVESDI (cm/m2)

1.9 ± 0.5

1.7 ± 0.3

1.8 ± 0.4

0.024

 LV mass index (g/m2)

133.9 ± 47.0

108.5 ± 39.1

128.3 ± 46.5

 < 0.001

 LVEF (%)

57.9 ± 6.5

58.6 ± 6.5

58.0 ± 6.5

0.374

CMR data indexed to BSA

   

 LVEDVI (ml/m2)

125.6 ± 39.4

96.8 ± 27.0

119.2 ± 38.9

 < 0.001

 LVESVI (ml/m2)

54.5 ± 23.8

41.1 ± 16.4

51.5 ± 23.0

 < 0.001

 LVEDDI (cm/m2)

2.9 ± 0.54

2.8 ± 0.51

2.9 ± 0.53

0.520

 LVESDI (cm/m2)

1.9 ± 0.5

1.8 ± 0.5

1.9 ± 0.5

0.300

 Length

9.7 ± 1.1

8.3 ± 0.7

9.4 ± 1.2

 < 0.001

 LV mass index (g/m2)

78.3 ± 27.1

66.2 ± 22.4

75.7 ± 26.6

 < 0.001

LVEF (%)

57.5 ± 6.5

58.3 ± 6.9

57.7 ± 6.6

0.733

RF

28.1 ± 15.5

21.2 ± 17.5

26.4 ± 16.2

0.001

RV

38.9 + 29.8

18.0 ± 16.4

34.0 ± 28.6

 < 0.001

HFR

35.3%

27.0%

33.7%

0.439

Echocardiographic data—indexed to height

   

 LVEDVI (ml/m2.7)

37.8 ± 13.7

28.8 ± 11.6

35.8 ± 13.8

 < 0.001

 LVESVI (ml/m2.7)

15.8 ± 7.9

11.9 ± 6.8

15.0 ± 7.8

 < 0.001

 LVEDDI (cm/m2.7)

1.2 ± 0.22

1.3 ± 0.19

1.2 ± 0.22

0.009

 LVESDI (cm/m2.7)

0.78 ± 0.17

0.81 ± 0.14

0.79 ± 0.16

0.131

 LV mass index (g/m2.7)

58.4 ± 20.5

53.7 ± 19.9

57.4 ± 20.4

0.038

CMR data indexed to height

    

 LVEDVI (ml/m2.7)

53.7 ± 17.3

46.4 ± 14.1

52.0 ± 16.9

0.002

 LVESVI (ml/m2.7)

23.2 ± 10.2

19.7 ± 8.1

22.4 ± 9.8

0.005

 LVEDDI (cm/m2.7)

1.2 ± 0.21

1.4 ± 0.22

1.3 ± 0.22

 < 0.001

 LVESDI (cm/m2.7)

0.80 ± 0.18

0.87 ± 0.21

0.82 ± 0.19

0.019

 LVMi (g/m2.7)

33.9 ± 12.4

32.1 ± 12.3

33.5 ± 12.4

0.231

  1. Continuous variables are expressed as mean ± standard deviation and categorical variables are expressed as number (percent)
  2. BSA body surface area, CMR cardiovascular magnetic resonance, HFR holodiastolic flow reversal, NYHA New York Heart Association, LVEDDI left ventricular end-diastolic dimension index, LVEDVI left ventricular end-diastolic volume index, LVESDI left ventricular end-systolic dimension index, LVESVI left ventricular end-systolic volume index, LV left lentricle/left ventricular mass index, LVEF left ventricular mass index, RF regurgitant fraction, RV regurgitant volume